Apheresis Market by Product Type, Distribution Channel, End User 2024-2032
                     Global Apheresis 
Market Research and 
Forecast Report 2024-
2032
Format: PDF+EXCEL
© 2023 IMARC All Rights Reserved 
About IMARC Group
IMARC Group is  a g lobal  management  consul t ing f i rm that  he lps the wor ld ’s  most  ambi t ious 
changemakers  to create a las t ing impact .  Across the s ix  major  cont inents  and 100+ count r ies ,  we 
work a longside our  bus iness par tners  as one team wi th  a common ambi t ion to achieve unparal le led 
resul ts ,  gain a compet i t ive edge,  and t ransform indust r ies .  IMARC Group excels  in  unders tanding 
i ts  c l ients ’  bus iness pr ior i t ies  and del iver ing ta i lored solut ions that  dr ive meaningfu l  outcomes.  Our 
c l ient  base spans over  3,000 organizat ions in  the pr ivate,  publ ic ,  and soc ia l  sectors ,  ranging f rom 
high-growth s tar tups to For tune 500 companies.
We prov ide a comprehensive sui te of  market  entry  and expansion serv ices.  Our of fer ings inc lude 
thorough market  assessment ,  feas ib i l i ty  s tudies,  company incorporat ion ass is tance,  fac tory  setup 
suppor t ,  regulatory  approvals and l icens ing navigat ion,  branding,  market ing and sales st rategies,  
compet i t ive landscape and benchmark ing analyses,  pr ic ing and cost  research,  and procurement  
research.  These serv ices are des igned to ass is t  companies in  evaluat ing market  oppor tuni t ies ,  
set t ing up new ent i t ies ,  navigat ing regulatory landscapes,  boost ing brand v is ib i l i ty ,  analyz ing 
compet i tors,  and opt imiz ing procurement  s t rategies.
A c c o r d i n g  t o  t h e  l a t e s t  r e p o r t  b y  I M A R C  G r o u p ,  t i t l e d  " A p h e r e s is  M a r k e t :  G l o b a l  
In d u s t r y  T r e n d s ,  S h a r e ,  S i z e ,  G r o w t h ,  O p p o r t u n i t y  a n d  F o r e c a s t  2 0 2 4 -
2 0 3 2 , "  t h e  g l o b a l  a p h e r e s i s  m a r k e t  s i z e  r e a c h e d  U S $  2 .9  B i l l i o n  i n  2 0 2 3 .
F a c to rs  A f fe c t in g  th e  G ro w th  o f  th e  A p h e re s is  In d u s t ry :
Report I n c re a s in g  P re v a le n c e  o f  C h ro n ic  D is e a s e s :
C h r o n i c  d i s e a s e s ,  s u c h  a s  c a n c e r ,  a u t o i m m u n e  d i s o r d e r s ,  a n d  b l o o d - r e l a t e d  c o n d i t i o n s ,  
o f t e n  r e q u i r e  t h e r a p e u t i c  i n t e r v e n t i o n s  t h a t  i n v o l v e  r e m o v i n g  h a r m f u l  c o m p o n e n t s  f r o m  th e  
Highlight and b l o o d .  A p h e r e s i s  p r o c e d u r e s  e n a b l e  t h e  s e l e c t i v e  r e m o v a l  o f  t h e s e  c o m p o n e n t s ,  t h e r e b y  
h e l p i n g  t o  m a n a g e  t h e  s y m p to m s  a n d  p r o g r e s s i o n  o f  t h e s e  d i s e a s e s .  
A p h e r e s i s  t e c h n i q u e s  a r e  a l s o  u s e d  f o r  d i a g n o s t i c  p u r p o s e s  i n  v a r i o u s  c h r o n i c  d i s e a s e s .  
Description A p h e r e s i s  c a n  a l s o  h e l p  i n  a n a l y z i n g  s p e c i f i c  b l o o d  c o m p o n e n t s  o r  i d e n t i f y i n g  b i o m a r k e r s  
a s s o c i a t e d  w i t h  c e r t a i n  c o n d i t i o n s ,  a i d i n g  i n  d i s e a s e  d i a g n o s i s  a n d  m o n i t o r i n g .
T e c h n o lo g ic a l  A d v a n c em e n ts :
I n n o v a t i o n s  i n  a p h e r e s i s  t e c h n o l o g y  a r e  l e a d i n g  t o  t h e  d e v e l o p m e n t  o f  m o r e  e f f i c i e n t  
s y s t e m s  f o r  b l o o d  c o m p o n e n t  s e p a r a t i o n .  T h e s e  a d v a n c e m e n t s  e n a b l e  h i g h e r  t h r o u g h p u t ,  
s h o r t e r  p r o c e d u r e  t i m e s ,  a n d  i n c r e a s e d  c o l l e c t i o n  y i e l d s ,  e n h a n c i n g  t h e  o v e r a l l  e f f i c i e n c y  
o f  a p h e r e s i s  p r o c e d u r e s .
Modern apheres is  machines incorporate sophis t icated automat ion and 
cont ro l  features that  a l low for  prec ise manipu la t ion of  b lood components.  
Th is  prec is ion ensures the accurate separat ion and co l lec t ion of  spec i f ic  
b lood components ,  min imiz ing the r isk  o f  procedura l  er rors  and improving 
pat ient  outcomes.
Growing Demand for  Blood Components:
Report Apheres is  procedures enable the se lec t ive co l lect ion of  spec i f ic  b lood 
components,  such as p la te le ts ,  p lasma,  and whi te  b lood ce l ls  (WBCs) .  
Highlight and These components  have d iverse therapeut ic  appl icat ions in  t ransfus ion 
medic ine,  hemato logy,  oncology,  and immunology.  
Description Plate le ts  p lay  a  cruc ia l  ro le  in  hemostas is  and are f requent ly  needed for  pat ients w i th  b leeding d isorders ,  undergoing surgery ,  or  rece iv ing 
chemotherapy.  Apheresis  a l lows for  the ef f ic ient  co l lec t ion of  p la te le ts  
f rom s ing le  donors ,  meet ing the h igh demand for  these b lood products .
Request  for  a  PDF sample of  th is  report :  
ht tps : / /www. imarcgroup.com/apheres is-market / requestsample
Report Description
Global Apheresis Market Trends:
There is  a  growing emphasis on personal ized or  precis ion medic ine approaches,  which require  
ta i lored b lood component therapies co l lected through apheresis procedures to  meet indiv idual  
pat ient  needs. Apheresis procedures are f ind ing expanding therapeut ic  appl icat ions beyond 
tradi t ional  uses, inc lud ing the t reatment of  neurological  d isorders,  organ t ransplantat ion, and 
immune-mediated d iseases,  dr iv ing market  d ivers i f icat ion.
Ris ing awareness among heal thcare professionals and pat ients about  the benef i ts  of  apheresis 
procedures is  leading to h igher acceptance and ut i l izat ion of  these techniques,  contr ibut ing to  the 
market growth.
View Report  TOC, Figures and Tables :  https:/ /www.imarcgroup.com/apheresis-market
Breakup by Component:
• Plasma (P lasmapheresis)
• Plate lets (P late letpheresis)
• Leukocytes (Leukapheres is  or  Leukopheres is)
• Lymphocytes (Lymphopheresis  or  
Lymphapheres is)
• RBC's (Erythropheres is)
Report 
Segmentation Breakup by Product:
• Devices
• Disposables  and Reagents
• Software
Breakup by Technology:
• Centr i fugat ion
• Membrane Separation
• Selective Adsorpt ion
Breakup by Procedure:
• Donor/Automated Apheresis
• Therapeutic Apheresis
Report 
Segmentation Breakup by Application:
• Renal Disorders
• Hematological  Disorders
• Neurological  Disorders
• Autoimmune Disorders
• Others
Breakup by End User:
• Blood Centers
• Hospitals
• Others
Breakup by Region:
Report • North America
Segmentation • Asia-Pacifi c
• Europe
• Latin America
• Middle East and Afr ica
• Asahi Kasei Medical Co. Ltd.  (Asahi Kasei 
Corporation)
• B. Braun SE
• Charles River Laboratories International 
Inc.
Competitive • Fresenius Medical Care AG & Co. KGaA
• Haemonetics Corporation
Landscape 
• Haier Biomedical
with Key • Kaneka Corporation
Players • Medica S.p.a.
• Miltenyi Biotec
• Nikkiso Co. Ltd.
• Sb-Kawasumi Laboratories Inc.  (Sumitomo 
Bakel ite Company Limited)
• Terumo Bct Inc.  (Terumo Corporation).
What was the size of the global apheresis market in 
2023?
What is the expected growth rate of the global 
apheresis market during 2024-2032?
Key What are the key factors driving the global 
apheresis market?
Questions 
Answered in What has been the impact of COVID-19 on the global apheresis market?
the Report
What is the breakup of the global apheresis market 
based on the component?
What is the breakup of the global apheresis market 
based on the product?
What is the breakup of the global apheresis market 
based on the technology?
What is the breakup of the global apheresis market 
based on procedure?
What is the breakup of the global apheresis market 
based on the application?
Key What is the breakup of the global apheresis market 
based on the end user?
Questions 
Answered in What are the key regions in the global apheresis market?
the Report
Who are the key players/companies in the global 
apheresis market?
1     P r e f a c e
2     S c o p e  a n d  M e t h o d o l o g y
    2 . 1     O b j e c t i v e s  o f  t h e  S t u d y
    2 . 2     S t a k e h o l d e r s
    2 . 3     D a t a  S o u r c e s
        2 . 3 . 1     P r i m a r y  S o u r c e s
        2 . 3 . 2     S e c o n d a r y  S o u r c e s
    2 . 4     M a r k e t  E s t i m a t i o n
Table of         2 . 4 . 1     B o t t o m - U p  A p p r o a c h        2 . 4 . 2     T o p - D o w n  A p p r o a c h
    2 . 5     F o r e c a s t i n g  M e t h o d o l o g y
3     E x e c u t i v e  S u m m a r y
4     I n t r o d u c t i o n
Contents     4 . 1     O v e r v i e w    4 . 2     K e y  I n d u s t r y  T r e n d s5     G l o b a l  A p h e r e s i s  M a r k e t
    5 . 1     M a r k e t  O v e r v i e w
    5 . 2     M a r k e t  P e r f o r m a n c e
    5 . 3     I m p a c t  o f  C O V I D - 1 9
    5 . 4     M a r k e t  F o r e c a s t
6      M a r k e t  B r e a k u p  b y  C o m p o n e n t
    6 . 1     P l a s m a  ( P l a s m a p h e r e s i s )
        6 . 1 . 1  M a r k e t  T r e n d s
        6 . 1 . 2  M a r k e t  F o r e c a s t
    6 . 2     P l a t e l e t s  ( P l a t e l e t p h e r e s i s )
        6 . 2 . 1  M a r k e t  T r e n d s
        6 . 2 . 2  M a r k e t  F o r e c a s t
    6 . 3     L e u k o c y t e s  ( L e u k a p h e r e s i s  o r  L e u k o p h e r e s i s )
        6 . 3 . 1  M a r k e t  T r e n d s
        6 . 3 . 2  M a r k e t  F o r e c a s t
       
    6 . 4     L y m p h o c y t e s  ( L y m p h o p h e r e s i s  o r  L y m p h a p h e r e s i s )
        6 . 4 . 1  M a r k e t  T r e n d s
        6 . 4 . 2  M a r k e t  F o r e c a s t
    6 . 5     R B C ' s  ( E r y t h r o p h e r e s i s )
        6 . 5 . 1  M a r k e t  T r e n d s
        6 . 5 . 2  M a r k e t  F o r e c a s t
7    M a r k e t  B r e a k u p  b y  P r o d u c t
    7 . 1     D e v i c e s
        7 . 1 . 1  M a r k e t  T r e n d s
        7 . 1 . 2  M a r k e t  F o r e c a s t
    7 . 2     D i s p o s a b l e s  a n d  R e a g e n t s
        7 . 2 . 1  M a r k e t  T r e n d s
Table of         7 . 2 . 2  M a r k e t  F o r e c a s t
    7 . 3     S o f t w a r e
        7 . 3 . 1  M a r k e t  T r e n d s
Contents         7 . 3 . 2  M a r k e t  F o r e c a s t8    M a r k e t  B r e a k u p  b y  T e c h n o l o g y
    8 . 1     C e n t r i f u g a t i o n
        8 . 1 . 1  M a r k e t  T r e n d s
        8 . 1 . 2  M a r k e t  F o r e c a s t
    8 . 2     M e m b r a n e  S e p a r a t i o n
        8 . 2 . 1  M a r k e t  T r e n d s
        8 . 2 . 2  M a r k e t  F o r e c a s t
    8 . 3     S e l e c t i v e  A d s o r p t i o n
        8 . 3 . 1  M a r k e t  T r e n d s
        8 . 3 . 2  M a r k e t  F o r e c a s t
9    M a r k e t  B r e a k u p  b y  P r o c e d u r e
    9 . 1     D o n o r / A u t o m a t e d  A p h e r e s i s
        9 . 1 . 1  M a r k e t  T r e n d s
        9 . 1 . 2  M a r k e t  F o r e c a s t
F o r  m o r e  i n f o r m a t i o n ,  v i s i t :  
h t t p s : / / w w w. im a rcg ro u p . co m / a ph e res i s - m a r ke t / t o c
Partial List of Clients
Partial List of Clients
Disclaimer
© 2024  IMARC Al l  R ights  Reserved 
Th is  Pub l i ca t ion  and  a l l  i t ’ s  con ten ts  un less  o therw ise  men t i oned  a re  copy r i gh ted  in  the  name o f  
I n t e rna t i ona l  Marke t  Ana lys i s  Research  and  Consu l t ing  ( IMARC) .  No  pa r t  o f  t h i s  pub l i ca t ion  may  be  
rep roduced ,  repackaged ,  red i s t r i bu ted  o r  res o ld  i n  who le  o r  i n  any  pa r t .  The  pub l i ca t ion  may  a l so  
no t  be  used  i n  any  f o rm o r  by  and means  g raph i c  e lec t ron ic  o r  mechan ic a l ,  i nc lud ing  pho tocopy ing ,  
reco rd ing ,  t ap ing  o r  by  i n fo rmat i on  s to rage  o r  re t r ieva l ,  o r  by  any  o the r  f o rm,  w i t hou t  the  exp ress  
c ons en t  o f  I n t e rna t iona l  Marke t  Ana lys i s  Research  and  Consu l t i ng  ( IMARC) .
Disc la imer :  Al l  con ten ts  and  da ta  o f  t h i s  pub l i c a t i on ,  i nc lud ing  fo recas t s ,  da ta  ana lys i s  and  op in ion  
have  been  based  on  in f o rmat ion  and  sources  be l ieved  to  be  accu ra te  and  re l iab le  a t  t he  t ime  o f  
pub l i sh ing .  In t e rna t i ona l  Ma rke t  Ana l ys is  Research  and  Consu l t ing  makes  no  rep resen ta t ion  o f  
war ran t y  o f  any  k ind  as  to  t he  acc u racy  o r  comp le teness  o f  any  I n fo rmat i on  p rov ided .  IMARC 
accep ts  no  l i ab i l i t y  wha tsoever  f o r  any  los s  o r  damage  resu l t i ng  f rom op in ion ,  e r ro rs  o r  
i naccu rac ies  i f  any  f ound  th is  pub l i ca t ion .
IMARC,  IMARC Group  and  G loba l  Therapy  I ns igh t  Ser i es  a re  reg is t e red  t rademarks  o f  I n te rna t iona l  
Marke t  Ana lys i s  Research  and  Consu l t ing .  A l l  o the r  t rademarks  used  i n  th i s  pub l i ca t i on  a re  
reg i s te red  t rademarks  o f  t he i r  r espec t i ve  compan ies .
Contact Us
Visit us at :
https://www.imarcgroup.com
+1-631-791-1145
[email protected]
Stay With Us: